Earnings Feed
Start Free
Home/Filings/4/0001179110-07-002561
4//SEC Filing

GIMBERT JOAN PONS 4

Accession 0001179110-07-002561

CIK 0001001316other
View on SEC.govCompany Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 8:51 AM ET

Size

11.2 KB

Accession

0001179110-07-002561

Insider Transaction Report

Form 4
Period: 2007-01-30
MANHATTAN PHARMACEUTICALS INCMHA
GIMBERT JOAN PONS
Director
Transactions
  • Award

    Common Stock

    2007-01-30+2,112→ 2,112 total
  • Award

    Director Stock Option

    2007-01-30+50,000→ 50,000 total
    Exercise: $0.71Exp: 2017-01-30→ Common Stock (50,000 underlying)
Holdings

  • Director Stock Option

    Exercise: $1.00Exp: 2015-01-11→ Common Stock (25,000 underlying)
    25,000

  • Common Stock

    (indirect: By Oleoyl-Estrone Developments SL)
    3,957,037

  • Option

    Exercise: $1.65Exp: 2014-01-27→ Common Stock (75,000 underlying)
    75,000
Footnotes (6)
  • [F1]The Reporting Person is the chief executive officer of Oleoyl-Estrone Developments SL, a company of unlimited duration registered in the Registro Mercantil of Carcelona ("OED"). The Reporting Person disclaims beneficial Ownership of the shares owned by OED.
  • [F2]Under the 2003 Stock Option Plan.
  • [F3]Stock issued in lieu of Director's fees due; based on closing stock price on January 30, 2007.
  • [F4]25,000 shares have vested. 25,000 shares vest, if at all, on 1/28/05 and 1/28/06, respectively.
  • [F5]8,334 shares vest on 1/11/05, 8,333 shares vest on each of 1/11/06 and 1/11/07.
  • [F6]16,667 shares vest on each of 1/30/07 and 1/30/08; 16,666 shares vest on 1/30/09.

Documents

1 file

Issuer

MANHATTAN PHARMACEUTICALS INC

CIK 0001001316

→
Entity typeother

Related Parties

1
  • filerCIK 0001221445

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:51 AM ET
Size
11.2 KB
View on SEC.gov